Literature DB >> 28162780

The value of old drugs for juvenile idiopathic arthritis.

Nico Wulffraat1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28162780     DOI： 10.1016/S0140-6736(17)30180-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  2 in total

1.  Disease activity and damage in juvenile idiopathic arthritis: methotrexate era versus biologic era.

Authors:  Gabriella Giancane; Valentina Muratore; Valentina Marzetti; Neus Quilis; Belen Serrano Benavente; Francesca Bagnasco; Alessandra Alongi; Adele Civino; Lorenzo Quartulli; Alessandro Consolaro; Angelo Ravelli
Journal:  Arthritis Res Ther       Date:  2019-07-08       Impact factor: 5.156

2.  Pharmacological conditioning for juvenile idiopathic arthritis: a potential solution to reduce methotrexate intolerance.

Authors:  Rosanne M Smits; Dieuwke S Veldhuijzen; Henriet van Middendorp; Petra C E Hissink Muller; Wineke Armbrust; Elizabeth Legger; Nico M Wulffraat; Andrea W M Evers
Journal:  Pediatr Rheumatol Online J       Date:  2020-02-07       Impact factor: 3.054
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.